Comerica Bank’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$819K Buy
65,946
+8,417
+15% +$112K ﹤0.01% 1628
2025
Q3
$824K Sell
57,529
-4,769
-8% -$65.3K ﹤0.01% 1648
2025
Q2
$764K Buy
62,298
+122
+0.2% +$1.77K ﹤0.01% 1664
2025
Q1
$1.37M Sell
62,176
-17,284
-22% -$406K 0.01% 1321
2024
Q4
$1.8M Sell
79,460
-1,317
-2% -$28.7K 0.01% 1190
2024
Q3
$1.47M Buy
80,777
+12,811
+19% +$297K 0.01% 1323
2024
Q2
$1.98M Sell
67,966
-7,555
-10% -$224K 0.01% 1135
2024
Q1
$2.68M Sell
75,521
-1,013
-1% -$40.5K 0.01% 1043
2023
Q4
$3.33M Buy
76,534
+790
+1% +$31.1K 0.02% 901
2023
Q3
$2.89M Buy
75,744
+55,386
+272% +$2.33M 0.02% 900
2023
Q2
$5 Buy
+20,358
New +$980K ﹤0.01% 459
2022
Q4
$1.86M Sell
33,020
-526
-2% -$26.8K 0.01% 1126
2022
Q3
$1.45M Sell
33,546
-461
-1% -$23.6K 0.01% 1252
2022
Q2
$1.85M Sell
34,007
-2,004
-6% -$120K 0.02% 1156
2022
Q1
$2.34M Buy
36,011
+2,286
+7% +$151K 0.02% 1065
2021
Q4
$2.21M Sell
33,725
-360
-1% -$24.4K 0.02% 1092
2021
Q3
$2.41M Sell
34,085
-5,821
-15% -$411K 0.01% 1174
2021
Q2
$2.83M Sell
39,906
-680
-2% -$48.1K 0.02% 1083
2021
Q1
$3.03M Sell
40,586
-2,252
-5% -$153K 0.02% 1087
2020
Q4
$2.97M Sell
42,838
-2,813
-6% -$151K 0.02% 1042
2020
Q3
$2.24M Sell
45,651
-1,608
-3% -$76.5K 0.02% 1067
2020
Q2
$2.31M Buy
47,259
+1,717
+4% +$84.4K 0.02% 994
2020
Q1
$2.19M Buy
45,542
+1,286
+3% +$67.5K 0.02% 866
2019
Q4
$2.44M Buy
44,256
+423
+1% +$25.2K 0.02% 995
2019
Q3
$2.45M Sell
43,833
-239
-0.5% -$14.2K 0.02% 957
2019
Q2
$2.38M Sell
44,072
-4,436
-9% -$228K 0.02% 988
2019
Q1
$2.65M Buy
48,508
+1,239
+3% +$63.1K 0.02% 926
2018
Q4
$2.17M Buy
47,269
+861
+2% +$47.2K 0.02% 1046
2018
Q3
$2.89M Sell
46,408
-8,106
-15% -$504K 0.02% 878
2018
Q2
$3.45M Sell
54,514
-13,600
-20% -$842K 0.02% 884
2018
Q1
$3.83M Buy
68,114
+1,832
+3% +$96K 0.03% 808
2017
Q4
$3.39M Sell
66,282
-1,441
-2% -$70.5K 0.02% 923
2017
Q3
$3.14M Buy
67,723
+3,195
+5% +$164K 0.02% 911
2017
Q2
$3.56M Sell
64,528
-2,614
-4% -$125K 0.03% 791
2017
Q1
$3.07M Buy
67,142
+2,616
+4% +$112K 0.02% 920
2016
Q4
$1.37M Buy
64,526
+3,206
+5% +$130K 0.01% 1437
2016
Q3
$2.51M Buy
61,320
+2,162
+4% +$90.6K 0.02% 922
2016
Q2
$2.5M Sell
59,158
-728
-1% -$26.2K 0.02% 910
2016
Q1
$2M Buy
59,886
+42
+0.1% +$1.31K 0.02% 1025
2015
Q4
$1.97M Buy
59,844
+802
+1% +$25.1K 0.02% 977
2015
Q3
$1.76M Sell
59,042
-70,137
-54% -$2.19M 0.02% 1095
2015
Q2
$3.56M Buy
129,179
+65,757
+104% +$1.75M 0.02% 1158
2015
Q1
$1.6M Sell
63,422
-60,913
-49% -$1.44M 0.01% 1222
2014
Q4
$2.76M Buy
124,335
+62,209
+100% +$1.26M 0.01% 1290
2014
Q3
$1.26M Buy
62,126
+4,264
+7% +$84.9K 0.01% 1354
2014
Q2
$1.11M Sell
57,862
-760
-1% -$14.2K 0.01% 1451
2014
Q1
$1.1M Sell
58,622
-1,588
-3% -$30.6K 0.01% 1483
2013
Q4
$1.17M Buy
60,210
+2,769
+5% +$50.8K 0.01% 1457
2013
Q3
$945K Buy
57,441
+1,522
+3% +$24.4K 0.01% 1679
2013
Q2
$837K Buy
+55,919
New +$819K 0.01% 1487

Other funds holding IART

Comerica Bank's IART Position: Q4 2025 in Review

Comerica Bank increased its Integra LifeSciences (IART) stake by 15% in Q4 2025, buying an estimated $112K and bringing the position to 65,946 shares worth $819K. The position accounts for ﹤0.01% of the portfolio, ranked #1628.

Comerica Bank first reported a position in IART in Q2 2013 and has held it in 50 quarters since. The position peaked at $3.83M in Q1 2018. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

  • Comerica Bank held 65,946 shares of Integra LifeSciences worth $819K as of Q4 2025.
  • Comerica Bank bought 8,417 Integra LifeSciences shares in Q4 2025, an estimated $112K.
  • Integra LifeSciences made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1628 holding.
  • Comerica Bank first reported a position in Integra LifeSciences in Q2 2013 and has held it in 50 quarters since.
  • Comerica Bank's Integra LifeSciences position peaked at $3.83M in Q1 2018.
  • 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.